Deferoxamine Toxicity

Deferoxamine Toxicity is a clinical phenomenon characterized by adverse physiological effects arising from the accumulation or administration of deferoxamine, a siderophore-based chelating agent, distinguished from other drug-related toxicities by its specific association with iron chelation therapy and its impact on cellular metabolism, microbial susceptibility, and organ function.

95

Publications

4.8K

Citations

419

Authors

173

Institutions

Publications per year

2017–2026

12

Authors

419

  1. GJ
    George J. Kontoghiorghes

    University College London, United Kingdom

    7 publications · 222 citations

    7

    h-index

  2. MH
    Melvin H. Freedman

    Hospital for Sick Children, Canada

    4 publications · 533 citations

    4

    h-index

  3. LH
    Lawrence Helson

    Memorial Sloan Kettering Cancer Center, United States

    3 publications · 275 citations

    3

    h-index

  4. NF
    Nancy F. Olivieri

    Hospital for Sick Children, Canada

    3 publications · 505 citations

    3

    h-index

  5. MT
    Meng Tian

    Sichuan University, China

    3 publications · 62 citations

    3

    h-index

1–5 of 419

Venues

  1. PubMed

    Repository · 16 publications · 765 citations

    13

    h-index

  2. Journal of Toxicology Clinical Toxicology

    2 publications · 53 citations

    2

    h-index

  3. Brain Research

    2 publications · 49 citations

    2

    h-index

  4. Retina

    2 publications · 100 citations

    2

    h-index

  5. Toxicology and Applied Pharmacology

    TAAP · 2 publications · 112 citations

    2

    h-index

1–5